...Qi Wang; Qisheng Lin; Linfeng Li; Weiyang Wei; Hao Yang; Yaqiang Huang Introduction: Although cystoscopy is highly accurate in managing bladder cancer, its invasive nature and high cost underscore the need for more practical, noninvasive alternatives. Urinary Twist Family BHLH Transcription Factor...

... and metastasis risk in bladder cancer patients through systematic review and meta-analysis, providing a scientific basis for clinicians’ individualized treatment decisions and risk stratification management for patients. Methods: Studies related to ctDNA in prognostic assessment of bladder cancer were screened...

...Kai Alexander Münker; David Reineke; Laila Schneidewind; Charlotte Müssgens Introduction: Distant metastases and especially single side metastases of non-muscle invasive bladder cancer (NMIBC) without regional progression in lymph nodes are extremely uncommon and rare. Case Presentation: We report...

...-free survival (PFS) after urological cancers. Results: A total of 20 studies were eligible. Three studies were on bladder cancer, four on prostate cancer, seven on renal cell carcinoma (RCC), and six on urothelial cancers. Meta-analysis showed that low GNRI was a statistically significant predictor...

... continence. Results: We included 79 patients who underwent RC for bladder cancer after prior prostatic intervention. Of them, 43 (54%) patients had previously undergone BPH surgery, 29 (37%) radical prostatectomy, and 7 (9%) prostate radiation therapy. An ileal conduit was performed in 62 (78%) cases...

... evaluated. The study focused on patients after radical prostatectomy (RP) for prostate cancer (PCa), radical cystectomy (RC) for bladder cancer (BCa), or (partial) nephrectomy for kidney cancer (KC). Results: Overall, 9,039 patients (6,898 (76.3%) after RP, 1,427 (15.8%) after RC, 714 (7.9%) after (partial...

... included surgical decision with 4 cases requiring extended resections, 3 ureteral stenting or anesthesiology decision in 8 cases, as well as 3 unknown cases. Once admitted to hospital, patients stayed a median of 2 IQR (1; 3) days. Outpatient care Bladder cancer Urothelial Complications Hematuria...

...-derived organoids (PDOs) are efficient and accurate neotype tumor models that can compensate for the deficiencies of traditional tumor models. Methods: From September 2023 to February 2024, bladder cancer tissues were collected from surgical resections in the Department of Urology, Beijing Tiantan...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Bladder cancer Non-muscle-invasive bladder cancer Prognosis Transurethral resection Tumor weight Transurethral resection of bladder tumors (TUR-BT...

...), and overall survival (OS) among patients with intermediate or high-risk non-muscle-invasive bladder cancer (NMIBC) receiving BCG was the primary aim of this systematic review and meta-analysis. Methods: In July 2023, we performed a literature search using MEDLINE, Embase, and the Cochrane Library. This study...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Bladder cancer Orthotopic diversion Subserous extramural tunnel Wallace Bladder cancer (BC) is the ninth most common cancer. After...

... cystectomy (RC) with urinary diversion (UD) are currently lacking. This study investigated the relationship between body image perception, social support, and QoL in bladder cancer patients who underwent RC with UD. Methods: A cross-sectional survey was conducted using validated general oncology tools...

... from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Bladder cancer Cystectomy Leukocytes Thrombocytes Bladder cancer is considered among the commonest cancer types worldwide, accounting for approximately 550,000 new cases every year...

.... The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Bladder cancer Bacillus Calmette-Guerin Disinfection Nonmuscle-invasive bladder cancer...

... the adaption of neoadjuvant chemotherapy (NAC) in patients with muscle-invasive bladder cancer (MIBC) in Germany, Austria, and Switzerland and especially underlying reasons for potential low adherence to guidelines. Methods: We conducted a non-validated survey among 336 urologic departments in Germany, Austria...

... metastatic SCC patients of our tertiary care hospital. Key Messages: Despite being the second most common variant histology of bladder cancer, current therapies for SCC do not provide satisfactory therapeutic responses. [email protected] 22 06 2023 14 10 2023 21 12 2023 © 2023...

...Yinsheng Guo; Chengbai Li; Shuhan Zhang; Guanhua Zhu; Lu Sun; Tao Jin; Ziyue Wang; Shiqing Li; Feng Zhou Introduction: Bladder cancer (BC) is a major health concern that poses a significant threat to the population, with an increasing incidence rate and a high risk of recurrence and progression...

...Lin Guo; Ting Zhang; Taisheng Liang; Jibing Chen; Hongjun Gao Background: Laparoscopic radical cystectomy (LRC) with ileal orthotopic neobladder (IONB) reconstruction is one of the most promising methods for bladder cancer treatment; its advantages include a small incision size, less blood loss...

..., instructions or products referred to in the content or advertisements. 2023 Anastomosis Bladder cancer Radical cystectomy Outcomes The gold standard in patients with muscle-invasive bladder cancer is the radical cystectomy (RC). This surgery is still regarded as a high-risk procedure despite...

... 05 2023 27 07 2023 Bladder cancer Urothelial carcinoma Cytology Transurethral resection of the bladder Sensitivity Diagnostic test Accurate histopathologic staging and grading are crucial in disease management of urothelial carcinoma of the bladder (BCa) as it may present...